International Clinical Trial: A Phase I Controlled and Phase II Single-Arm Study Evaluating the Safety, Hydration, and Brightening Efficacy of Glomix Skin Conditioner in Healthy Adult Volunteers at the University of Ruhuna

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (SLCTR/2026/023) titled 'A Phase I Controlled and Phase II Single-Arm Study Evaluating the Safety, Hydration, and Brightening Efficacy of Glomix Skin Conditioner in Healthy Adult Volunteers at the University of Ruhuna' on Sept. 5.

Study Type: Interventional

Study Design: Non-randomized controlled trial

Primary Sponsor: Technology Transfer Office (TTO), University of Ruhuna

Condition: Skin hydration and brightness/tone

Intervention: Two types of patches will be used: - Medicated Patch: Contains the Glomix Skin Conditioner - Non-medicated Patch: Contains the cream base (without actives)

The Phase I study will be conducted in three ...